The growth of this market can be attributed to the factors such as, increase in sports injuries and road accidents, awareness among patients & athletes, rise in obesity rate, and continuously aging population. According to the World Health Organization, 2017, fatal road accidents are the second primary cause of factures and accidental injury worldwide with almost 646000 individuals die every year around the world.
Major Key Players of the Orthobiologics Market are:
Medtronic, DePuy Synthes, Zimmer Biomet, MTF, Sanofi, Bioventus, Arthrex, Seikagaku and NuVasive among others.
Collaborations and rising R&D investments by the prominent biotechnology and medical device companies are leading to the introduction of advanced orthobiologics which is expected to widen the base for growth of the orthobiologics. For instance, Bone Biologics Corp., is in development stages of its orthobiological product bone growth stimulator Nell-1, in collaboration (2015) with the University of California. This subsequent increase in R&D efforts led to development of a series of pipeline products that is projected to provide the vertical with profitable growth opportunities in the future.
The Orthobiologics Market is segmented on the basis of Product, Applications and region.
Major Types of Orthobiologics Market covered are:
- Introduction & Definition
- Demineralized Bone Matrix (DBM)
- Bone Morphogenetic Protein
- Viscosupplementation
- Allograft
- Stem Cell Therapy
- Others
Major Applications of Orthobiologics Market covered are:
- Introduction
- Spinal Fusion
- Trauma
- Soft-Tissue Injuries
- Reconstructive Surgery
- Other Applications
No comments:
Post a Comment